JP Stock MarketDetailed Quotes

Shin Nippon Biomedical Laboratories (2395)

Watchlist

1197
-27-2.21%

20min DelayMarket Closed May 13 15:30 JST

49.83BMarket Cap10.91P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shin Nippon Biomedical Laboratories (2395) Key Financial Indicators

2395 Free Cash Flow (FCF)

Interested in knowing about Shin Nippon Biomedical Laboratories's free cash flow? The latest report shows it as 288.19M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: JPY

Quarterly

2395 Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Shin Nippon Biomedical Laboratories shows that the company's current ratio is 1.09, indicating healthy liquidity.

Currency: JPY

Quarterly

2395 Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Shin Nippon Biomedical Laboratories, the quick ratio is 0.66, indicating that the company can meet its short-term debt obligations.

Currency: JPY

Quarterly

2395 Return on Equity (ROE)

Want to learn more about the financial health of Shin Nippon Biomedical Laboratories? The latest ROE figure is 5.40%, indicating that the company has stable profitability.

Currency: JPY

Quarterly

2395 Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Shin Nippon Biomedical Laboratories, the total asset return on investment (ROA) is 2.35%.

Currency: JPY

Quarterly

2395 Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Shin Nippon Biomedical Laboratories's latest financial report to see how their gross margin is doing - currently at 47.38%.

Currency: JPY

Quarterly

2395 Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Shin Nippon Biomedical Laboratories, the net profit margin is 3.96%, which is a good sign for its profitability.

Currency: JPY

Quarterly

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm